Alain Monnier

TL;DR: Model Q230 proposed by Mariani and his co-workers satisfactorily fits the x-ray data collected on the cubic mesostructure material and suggests that the silicate polymer forms a unique infinite silicate sheet sitting on the gyroid minimal surface and separating the surfactant molecules into two disconnected volumes.

TL;DR: An interdisciplinary expert panel of clinical oncologists and of specialists in metabolic bone diseases assessed the widespread evidence and information on the efficacy of BP in the metastatic and nonmetastatic setting, as well as ongoing research on the adjuvant use of BP and recommends amino-bisphosphonates for patients with metastatic bone disease from breast cancer and zoledronic acid for Patients with other solid tumours as primary disease.

TL;DR: Letrozole is safe and effective in postmenopausal women with estrogen receptor‐positive early breast cancer, but long‐term aromatase inhibitor use may cause bone loss and increase fracture risk, so an immediate or delayed strategy of bone protection therapy with zoledronic acid is evaluated.

TL;DR: In this article, the authors used time-resolved X-ray diffraction to follow phase transitions in nanostructured silica/surfactant composites in real time under hydrothermal conditions.

TL;DR: In this article, the phase transformation of the hexagonal mesostructure MCM-41 to the cubic mesostructures (MCM-48) was examined by in situ X-ray diffraction (XRD) and by XRD of products from bulk transformation experiments in Parr autoclaves under conditions of high pH and temperatures between 100 and 190 °C.